Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Neoplasms 43Breast Neoplasms 31Prostatic Neoplasms 27Colorectal Neoplasms 26Lung Neoplasms 17Hematopoietic and Lymphatic System Neoplasm 12Ovarian Neoplasms 11Hematologic Neoplasms 11Uterine Cervical Neoplasms 7Multiple Myeloma 7Lymphoma 7Leukemia 7Head and Neck Neoplasms 6Endometrial Neoplasms 6Depression 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Leukemia, Myeloid, Acute 5Urinary Bladder Neoplasms 4Rectal Neoplasms 4Mouth Neoplasms 4Motor Activity 4Melanoma 4Hematopoietic and Lymphoid System Neoplasm 4Gastrointestinal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Anxiety Disorders 4Advanced Cancer 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3

Interventions

Imatinib Mesylate 32regorafenib 9Sunitinib 9Laparoscopy 5Dasatinib 4Blood Specimen Collection 4pazopanib 3nilotinib 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Paclitaxel 3Observation 3spartalizumab 2ripretinib 2envafolimab 2binimetinib 2apatinib 2Temozolomide 2Neoadjuvant Therapy 2Ipilimumab 2Gemcitabine 2Docetaxel 2Cisplatin 2Carboplatin 2Capecitabine 2CTLA-4 Antigen 2Biopsy, Fine-Needle 2Biopsy 25-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 24-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastrointestinal Stromal Tumors × Interviews as Topic × Clear all
NCT01178307 2020-01-13

Symptom Inventory for Gastrointestinal Stromal Tumors

M.D. Anderson Cancer Center

Unknown
187 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡